Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main United Therapeutics Corp Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in United Therapeutics Corp stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 12,613 shares of UTHR stock, worth $4.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,613

Previous 19,007 33.64%

Holding current value

$4.53 Million

Previous $6.05 Million 25.36%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$311.04 - $363.55 $1.99 Million - $2.32 Million	-6,394 Reduced 33.64%	12,613 $4.52 Million
Q2 2024 Aug 14, 2024	SELL	$228.26 - $319.04 $1.4 Million - $1.95 Million	-6,116 Reduced 24.34%	19,007 $6.05 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $1.11 Million - $1.32 Million	5,287 Added 26.65%	25,123 $5.77 Million
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $3.85 Million - $4.61 Million	-17,928 Reduced 47.47%	19,836 $4.36 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $1.44 Million - $1.68 Million	-6,775 Reduced 15.21%	37,764 $8.53 Million
Q2 2023 May 17, 2024	BUY	$205.19 - $232.99 $3.98 Million - $4.52 Million	19,416 Added 77.28%	44,539 $9.83 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $171,744 - $195,012	837 Added 1.92%	44,539 $9.83 Million
Q1 2023 May 17, 2024	BUY	$212.99 - $276.17 $1.23 Million - $1.59 Million	5,760 Added 15.18%	43,702 $9.79 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $1.23 Million - $1.59 Million	5,760 Added 15.18%	43,702 $9.79 Million
Q4 2022 May 17, 2024	BUY	$205.95 - $280.43 $2.64 Million - $3.59 Million	12,819 Added 51.02%	37,942 $10.6 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $4.24 Million - $5.78 Million	-20,610 Reduced 35.2%	37,942 $10.6 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $7.6 Million - $9.13 Million	37,390 Added 176.68%	58,552 $12.3 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $1.75 Million - $2.42 Million	10,039 Added 90.25%	21,162 $4.99 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $322,184 - $414,868	1,939 Added 21.11%	11,123 $2 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $516,280 - $605,240	2,801 Added 43.88%	9,184 $1.98 Million
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $982,599 - $1.12 Million	6,383 New	6,383 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $201,804 - $300,695	-1,981 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $197,901 - $239,958	1,981 New	1,981 $200,000
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $1.29 Million - $1.58 Million	-16,522 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $3.17 Million - $3.64 Million	-42,342 Reduced 71.93%	16,522 $1.32 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $20.3 Million - $32.3 Million	-267,209 Reduced 81.95%	58,864 $4.59 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $11.2 Million - $13.3 Million	104,571 Added 47.21%	326,073 $38.3 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $2.62 Million - $3.32 Million	25,793 Added 13.18%	221,502 $23.3 Million
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $2.71 Million - $3.09 Million	-23,847 Reduced 10.86%	195,709 $0
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $815,390 - $953,815	-8,062 Reduced 3.54%	219,556 $24.8 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $1.67 Million - $2.36 Million	-15,548 Reduced 6.39%	227,618 $25.6 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $5.36 Million - $6.84 Million	45,193 Added 22.83%	243,166 $36 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $22.7 Million - $27.1 Million	197,973	197,973 $23.2 Million

Others Institutions Holding UTHR

# of Institutions

668

Shares Held

42.8M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main United Therapeutics Corp Transaction History